Atrium Therapeutics, Inc.

Direct answer

Atrium Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RNA.

Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to revolutionizing the treatment of cardiomyopathies by delivering innovative ribonucleic acid (RNA) therapeutics directly to the heart. Their development-stage portfolio currently includes ATR 1072, a siRNA-based therapy targeting the PRKAG2 gene for the treatment of PRKAG2 syndrome, and ATR 1086, another siRNA therapy aimed at the PLN gene to...

Can you invest in Atrium Therapeutics, Inc.?

Yes. Atrium Therapeutics, Inc. trades publicly on NASDAQ as RNA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Atrium Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.